期刊文献+

日本血吸虫重组BCG-Sj26GST疫苗诱导小鼠脾细胞IL-6变化的研究 被引量:3

Study on the change of IL-6 in spleen cells of mice induced by recombinant BCG-Sj26GST vaccine of schistosoma japonicum
暂未订购
导出
摘要 目的: 研究日本血吸虫重组BCG-Sj26GST疫苗对小鼠脾细胞IL-6的影响。方法:实验1采用该疫苗皮下免疫小鼠,免疫后8周用日本血吸虫尾蚴进行攻击感染,感染后6周剖杀小鼠,同时设有PBS对照组。实验2用该疫苗皮下和静脉注射分别免疫小鼠,于免疫后0、4、8、10、14和16周各剖杀4只,分离脾脏,用Sj26或PHA刺激脾细胞,用ELISA法检测脾细胞上清液中IL-6含量。结果:疫苗免疫,尾蚴攻击后,IL-6水平无明显变化;动态观察发现IL-6于疫苗免疫后8~10周达最高水平。结论:IL-6可能与日本血吸虫重组BCG-Sj26GST疫苗诱导的保护性免疫力无关。 Objective: To study the effect of recombinant BCG-Sj26GST vaccine of schistosoma japonicum on IL-6 produced by spleen cells of mice. Methods: In the first experiment, mice were immunized subcutaneously by the vaccine, with PBS serving as control, challenged with Sj cercariae after 8w of immunization and killed on 6w of the infection to separate spleens; in the second experiment, after subcutaneous and intravenous immunization by the vaccine respectively, 4 mice were killed to separate spleens on 0,4,8,10,14 and 16w of immunization, spleen cells were stimulated by Sj26 or PHA, and the level of IL-6 in supernatant of spleen cells were detected by ELISA. Results: The level of IL-6 had no obvious change by immunization with the vaccine against challenge with Sj cercariae;dynamic observation showed that IL-6 reached the highest level on 8~10w of immunization. Conclusion: IL-6 may not be related to the protective immunity elicited in mice by vaccination with recombinant BCG-Sj26GST vaccine of schistosoma japonicum.
出处 《重庆医科大学学报》 CAS CSCD 2001年第2期148-150,共3页 Journal of Chongqing Medical University
关键词 日本血吸虫 生组BCG-Si26GST疫苗 IL-6 脾细胞 小鼠 Schistosoma japonicum;Recombinant BCG-Sj26GST vaccine ;IL-6
  • 相关文献

参考文献2

二级参考文献6

共引文献21

同被引文献37

  • 1钱建飞.动物基因工程疫苗研究进展[J].中国预防兽医学报,2000,22(S1):189-192. 被引量:3
  • 2闻玉梅.治疗性疫苗的研究进展[J].中华微生物学和免疫学杂志,1996,16(3):155-158. 被引量:24
  • 3李忠明,张延龄,徐德启,等.当代新疫苗.北京:高等教育出版社,2000.125-140.
  • 4Jacobs WR, Tuckman M, Bloom BR. Introduction of foreign DNA into mycobacteria using a shuttle plasmid. Nature, 1987, 327 (6122):532 - 534.
  • 5Stover CK, Bansal GP, Habson MS, et al. Protective immunity elicited by recombinant Bacille Calmett - Guerin (BCG) expression outer surface protein A (OspA) lipoprotein: a candidate lume disease vaccine. J ExPMed, 1993, 178: 197-209.
  • 6Webb JR, Vedvick TS, Alderson MR, et al. Molecular clonging, expression and immunogenicity of MTB12, a novel low - molecular weight antigen secreted by mycobacterium tuberculosis. Infect Immun,1998, 66: 4208-4214.
  • 7Verma IM, Somia N. Gene therapy- promises, problems and prospects.Nature, 1997,389: 239 - 242.
  • 8Cooper MJ, Lippa M, Payne JM, et al. Safety- modified episomal Vectors for human gene therapy. Proc. Natl Acad Sci USA, 1997, 94:6450 - 6455.
  • 9Matsumoto S, Yanagi T, Ohara N, et al. Stable expression and secretion of the B - cell epitope of rodent malaria from Mycobacterium bovis BCG and induction of long - lasting humoral response in mouse. Vaccine, 1996, 14 (1): 54-60.
  • 10Matsumoto S, Yukitake H, Kanbara H, et al. Recombinant Mycobacterium bovis bacilles Calmette - Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1 - stimulated interferon gamma and parasite specific antibodies. J Exp Med. 1998, 188: 845- 54.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部